Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 29.76% vs 12.53% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 9.20% vs -2.41% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -2.15% vs -38.47% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 4.30% vs 9.36% in Mar 2024
Compare Profit and Loss Results of Aristo Bio-Tech
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
318.00
90.00
228.00
253.33%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
318.00
90.00
228.00
253.33%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-2.00
2.00
100.00%
Raw Materials Consumed
295.00
57.00
238.00
417.54%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
4.00
9.00
-5.00
-55.56%
Operating Expenses
6.00
2.00
4.00
200.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
7.00
-7.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
2.00
-2.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
308.00
81.00
227.00
280.25%
Operating Profit (PBDIT) excl Other Income
9.00
9.00
0.00
0.00%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
9.00
9.00
0.00
0.00%
Interest
1.00
2.00
-1.00
-50.00%
Profit before Depriciation and Tax
8.00
7.00
1.00
14.29%
Depreciation
2.00
1.00
1.00
100.00%
Profit Before Taxation & Exceptional Items
5.00
5.00
0.00
0.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
5.00
5.00
0.00
0.00%
Provision for Tax
1.00
1.00
0.00
0.00%
Profit After Tax
4.00
3.00
1.00
33.33%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
16.00
1.00
15.00
1,500.00%
Profit Available for appropriations
20.00
5.00
15.00
300.00%
Appropriations
20.00
5.00
15.00
300.00%
Equity Dividend (%)
5%
0%
5.00
Earnings Per Share
5.97
7.48
-1.51
-20.19%
Profit And Loss - Net Sales
Net Sales 318.09 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 29.76% vs 12.53% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 9.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.20% vs -2.41% in Mar 2024
Profit And Loss - Interest
Interest 1.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.15% vs -38.47% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 4.06 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 4.30% vs 9.36% in Mar 2024






